The Beneficial Effects of Alpha Lipoic Acid Supplementation on Lp-PLA2 Mass and Its Distribution between HDL and apoB-Containing Lipoproteins in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Figure 4

Correlation between changes of ox- LDL and total Lp-PLA2 mass (a), changes of ox-LDL and apoB-associated Lp-PLA2 mass (b), changes of TG and percent of HDL-Lp-PLA2 (c), and changes of APO A1 and percent of HDL-Lp-PLA2 (d) after supplementation with ALA.

(a)

(b)

(c)

(d)